1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Strategy

Nestlé Health Science Refocuses As It Drops Peanut Allergy Treatment

 
• By Tom Gallen

VMS, active nutrition and medical nutrition will be Nestle Health Science's main focus areas going forward with the business looking to offload peanut allergy treatment Palforzia. The Swiss firm announced the move as it reported organic growth of 4% at Health Science for 2022.

• Source: Shutterstock

Nestlé Health Science will return its focus to consumer care and medical nutrition after confirming it is exploring “strategic options” for its peanut allergy treatment Palforzia.

Taking an impairment charge of CHF1.9bn ($2.1bn) on the brand, Nestlé blamed “slower than expected adoption by patients and healthcare professionals

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

Nestlé Health Science’s US VMS Recovery Stutters

 
• By Tom Gallen

US dietary supplement brand Nature's Bounty is yet to fully recover sales since supply issues forced it off shelves last year, according to Nestle's Q1 report.

US Consumer Health Market People News; BodyArmor, Just Ingredients, CRN/Radicle Award

 
• By Malcolm Spicer

CRN/Radicle Science expand Trailblazer Award nominations; BodyArmor brand relaunch with ‘Choose Better’ campaign and pro athletes; and Just Ingredients catches Bryce Harper as partner.

Italy’s PharmaNutra Grows Presence In Americas And MENA

 
• By Tom Gallen

Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.

Azelis Grows Nutraceuticals Offering In Iberia With Solchem

 
• By Tom Gallen

Azelis adds dietary supplement ingredients and a large customer base across Spain to its portfolio with the acquisition of Solchem Nature.

More from Business

Nestlé Health Science’s US VMS Recovery Stutters

 
• By Tom Gallen

US dietary supplement brand Nature's Bounty is yet to fully recover sales since supply issues forced it off shelves last year, according to Nestle's Q1 report.

OLLY Argues Standard Of Support For Kids Chillax Claims Casts Chill Over Supplement Advertising

 
• By Malcolm Spicer

NAD and NARB track their decisions on support for ad claims with Federal Trade Commission policies, including the requirement of RCTs to support health claims for supplements, a standard the industry argues is required for drug claims and shouldn’t be applied for dietary ingredients.

US Consumer Health Market People News: CHPA Foundation Contest, Celsius And AdvoCare Hires

 
• By Malcolm Spicer

CHPA Health In Hand Foundation accepting nominations for 2025 US Self-Care Marketing Awards; Celsius hires former PepsiCo as president/COO and closes $1.8bn acquisition of energy drink competitor Alani; and AdvoCare adds John Peirano as integrated marketing VP after hiring Kathy Blosser supply chain VP.